ConductScience.org, home

Trial · NCT00262639

Adverse event totals12

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityLow CIWA Flumazenil/Gabapentin
Total, all-cause mortalityLow CIWAar Placebo
Total, all-cause mortalityHigh CIWAar Placebo
Total, all-cause mortalityHigh CIWAar Flumazenil/Gabapentin
Total, other adverse eventsLow CIWA Flumazenil/Gabapentin018
Total, other adverse eventsLow CIWAar Placebo026
Total, other adverse eventsHigh CIWAar Placebo09
Total, other adverse eventsHigh CIWAar Flumazenil/Gabapentin07
Total, serious adverse eventsLow CIWA Flumazenil/Gabapentin018
Total, serious adverse eventsLow CIWAar Placebo026
Total, serious adverse eventsHigh CIWAar Placebo09
Total, serious adverse eventsHigh CIWAar Flumazenil/Gabapentin07

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00262639/event-totals